Candel Therapeutics (CADL)'s 30-day implied volatility (IV30) was 79.2% at the close on November 20, 2026, up from 55.3% the day before, against a 52-week range of 37.3% to 107.9%. Its 20-day historical volatility was 86.1%.
Data as of November 20, 2026.